ArticleOncotarget2018

Counteracting survival functions of EBNA3C in Epstein-Barr virus (EBV)-driven lymphoproliferative diseases by combination of SAHA and bortezomib.

Kwai Fung Hui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.